SCOTTSDALE, AZ / ACCESSWIRE / January 11, 2023 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company developed new CBD Oil infused with top-of-the-line terpenes and will be available to purchase in the next couple of days on LBC Bioscience Inc’s website.
LBC Bioscience Inc. has recently established a manufacturing facility for product development along with other operations, and the company has formulated a Premium Non-GMO tincture coming in strengths of 500MG, 1500MG, & 3000MG! This tincture will come in 14 different flavors and will be packed with some of the best terpenes on the market today. LBC Bioscience’s all-new powerhouse product boasts rapid absorption, four times the potency of other hemp-derived tinctures and stronger than any products the company currently carries. Its high-quality ingredient combination has shown impressive results with satisfaction following the sampling process. LBC’s new tincture is focused on assisting muscle discomfort, stress, and sleep deprivation.
President & CEO Lisa Nelson states, “For those that aren’t aware, terpenes are naturally occurring chemical compounds found in plants and some animals. They’re responsible for the aromas, flavors, and even colors associated with various types of vegetation. In terms of cannabis, terpenes are what make certain strains smell or taste different from others.”
Lisa Nelson also stated, “This is going to be a great year for our wholesale division along with significant revenue increase and growth as we continue to expand our product line!”
All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. In 2023, LBC Bioscience Inc. will continue to strive to improve its customers’ daily lives with high-quality premium products that are not only easily accessible, but affordable.
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson’s, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn’s, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to receive help from CBD. More news to come!
LBC BIOSCIENCE INC. ONLINE STORE
LBC BIOSCIENCE’S Online Emporium
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings – all at very reasonable prices. Check out LBC Bioscience Inc’s newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top-selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
Become a distributor
Large Selection of Products (over 50 items and growing)
100% USA Made Products “organic & kosher.”
All Products are THC-FREE (they contain 0.00% THC)
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc’s Main Website at www.lbcbioscienceinc.com
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles , Coffee, Skincare Line, Pet Line, Tablets and more. LBC’s products can be viewed and bought on the Company’s website at www.lbcbioscienceinc.com.
Ten Associates LLC
Contact: Thomas E Nelson
Telephone: (480) 326-8577
E-mail: [email protected]
Except for the historical information contained in, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc’s, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com: